$80K — $100K *
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases.
The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology.
What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.
We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.
We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.
Description of Position:
BlueRock Therapeutics is seeking a highly motivated Scientist II / Senior Scientist (Macrophage) for our Immunology team in Cambridge, MA. The successful candidate will have strong expertise in Immunology and Macrophage biology and is expected to play an integral role in the team. Reporting to the VP Immunology, this individual will engineer novel immune cell therapies derived from induced Pluripotent Stem Cells (iPSC) for the treatment of inflammatory or autoimmune diseases. This is an exciting and challenging opportunity to contribute to bringing a new class of cellular therapies to patients with inflammatory or autoimmune diseases using our unique CELL+GENE platform.
Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.
Valid through: 3/6/2021
$100K — $150K
6 days ago